| Application no. and date | 15191756.4 (espacenet) (Federated) (European Patent Register), 20080530 | | Patent/reg. no. and date | DK/EP 3002009, 20210707 | | Publication date | 20160406 | | Priority no. and date | US 932650 P, 20070601 | | EP pub. no. and date |
EP 3002009 20160406 | | Effective date | | | Applicant/owner | Wyeth LLC, 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | V345065DK00 | | Inventor | HEWES, Becker, 45 Myrtle Terrace
Winchester, MA Massachusetts 01890, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4709 (2006.01) , A61K 31/496 (2006.01) , A61P 35/02 (2006.01) | | Title | BEHANDLING AF IMATINIB-RESISTENT KRONISK MYELOID LEUKÆMI, SOM HAR MUTATIONEN 1457T>C I BCRABL-GENET, UNDER ANVENDELSE AF FORBINDELSEN BOSUTINIB | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
